Effect of standard nicotinamide in the prevention of type 1 diabetes in first degree relatives of persons with type 1 diabetes - Concepedia

Concepedia

Publication | Closed Access

Effect of standard nicotinamide in the prevention of type 1 diabetes in first degree relatives of persons with type 1 diabetes

30

Citations

36

References

2006

Year

Eduardo Cabrera‐Rode, Gisela Molina, Celeste Arranz, Manuel Vera, Pedro González, Rolando Suárez, Mirta Prieto, Saul Alejandro Padron, Rafael León, Juana Tillán,

Abstract

Type 1 diabetes prevention trial using standard nicotinamide is feasible but fails to prevent or delay the disease onset at the dose we used.

References

	Year	Citations
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man David R. Matthews, J P Hosker, A. Rudenski, Diabetologia Insulin ResistanceObesityMetabolic SyndromeBody CompositionHealth Sciences	1985	31K
Determination of Glucose in Blood Using Glucose Oxidase with an Alternative Oxygen Acceptor P. Trinder Annals of Clinical Biochemistry International Journal of Laboratory Medicine BiochemistryBioanalysisPhysiologyDiabetesAlternative Oxygen Acceptor	1969	4.6K
Diabetes Mellitus: Report of a WHO Study Group. Annals of Internal Medicine Diabetes ManagementDiabetes EpidemiologyHealth PolicyDiabetesDiabetes Complications	1986	1K
Effects of Insulin in Relatives of Patients with Type 1 Diabetes Mellitus New England Journal of Medicine	2002	837
Separation of leukocytes from blood and bone marrow. Introduction. PubMed ImmunohematologyLaboratory HematologyGranulocyteImmunologyHematology	1968	696
Effects of Oral Insulin in Relatives of Patients With Type 1 Diabetes Diabetes Care	2005	665
European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes Edwin Gale The Lancet Type 1Randomised Controlled TrialNon-pharmacological InterventionDiabetes ManagementHealth Policy	2004	534
Statistical Tables for the Design of Clinical Trials. C Wickham, David Machin, Michael J. Campbell Journal of the Royal Statistical Society Series A (Statistics in Society) Statistical TablesRandomization BibliographyEpidemiologyClinical Trial DesignClinical Trial Analysis	1988	433
Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop. Charles F. Verge, David Stenger, Ezio Bonifacio, Diabetes	1998	424
A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM C. E. Grubin, T. Daniels, Bert Toivola, Diabetologia Autoimmune DiseaseMedicineBioanalysisImmunologyPathology	1994	404

Page 1